In search for the Holy Grail: Suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: A position paper from the study group on biomarkers of the Acute Cardiovascular Care Association

European Heart Journal: Acute Cardiovascular Care

Volumn 3, Issue 4, 2014, Pages 313-316

  Jaffe, Allan S ^a   Moeckel, Martin ^b   Giannitsis, Evangelos ^c   Huber, Kurt ^d   Mair, Johannes ^e   Mueller, Christian ^f   Plebani, Mario ^g   Thygesen, Kristian ^h   Lindahl, Bertil ⁱ  

^a MAYO CLINIC   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d WILHELMINEN HOSPITAL   (Austria)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

ⁱ UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; TROPONIN I;

CLINICAL COMPETENCE; HUMAN; METABOLISM; MYOCARDIAL INFARCTION; PATIENT SELECTION; STANDARD;

BIOMARKERS; CLINICAL COMPETENCE; CREATINE KINASE, MB FORM; HUMANS; MYOCARDIAL INFARCTION; PATIENT SELECTION; REFERENCE STANDARDS; TROPONIN I;

EID: 84965094182     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872614541906     Document Type: Article

References (15)

1. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012; 33: 2551–2567.
2. Apple FS and Collinson PO. IFCC task force on clinical applications of cardiac biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012; 58: 54–61.
3. White HD. Higher sensitivity troponin levels in the community: what do they mean and how will the diagnosis of myocardial infarction be made? Am Hrt J 2010, 159: 933–936.
4. Reichlin T, Irfan A, Twerenbold R, et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circ 2011; 124: 136–145.
5. Giannitsis E, Becker M, Kurz K, et al. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010; 56: 642–650.
6. Apple FS, Smith SW, Pearce LA, et al. Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay. Clin Biochem 2012; 45: 711–713.
7. Keller T, Zeller T, Ojeda F, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011; 306: 2684–2693.
8. Jaffe AS, Babuin L and Apple FS. Biomarkers in acute cardiac disease – The present and the future. J Am Coll Cardiol 2006; 48: 1–11.
9. Hammarsten O, Fu ML, Sigurjonsdottir R, et al. Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction. Clin Chem 2012; 58: 628–637.
10. Bjurman C, Larsson M, Johanson P, et al. Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality. JACC 2013; 62: 1231–1238.
11. Braunwald E and Morrow DA. Unstable angina: is it time for a requiem? Circ 2013; 127: 2452–2457.
12. Santalȯ M, Martin A, Velilla J, et al. Using high-sensitivity Troponin T: the importance of the proper Gold Standard. Am J Med 2013; 126: 709–717.
13. Saaby L, Poulsen TS, Hosbond S, et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med 2013; 126: 789–797.
14. Hamm CW, Bassand JP, Agewall S, et al., and the ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999–3054.
15. Korosoglou G, Lehrke S, Mueller D, et al. Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart 2011; 97: 785–786.